Page last updated: 2024-10-22

albuterol and Limb-Girdle Muscular Dystrophies

albuterol has been researched along with Limb-Girdle Muscular Dystrophies in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"This family needs to be reclassified as congenital myasthenic syndrome rather than congenital muscular dystrophy."1.39DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy. ( Abicht, A; Lochmüller, H; Mahjneh, I; Muntoni, F, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahjneh, I1
Lochmüller, H1
Muntoni, F1
Abicht, A1

Other Studies

1 other study available for albuterol and Limb-Girdle Muscular Dystrophies

ArticleYear
DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.
    Neuromuscular disorders : NMD, 2013, Volume: 23, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Diagnosis, Differential; Ephedrine; Female; H

2013